Apyx Medical
APYX
71 hedge funds and large institutions have $128M invested in Apyx Medical in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 25 reducing their positions, and 13 closing their positions.
1.24% more ownership
Funds ownership: 55.64% → 56.88% (+1.2%)
8% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 25
5% less funds holding
Funds holding: 75 → 71 (-4)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
48% less capital invested
Capital invested by funds: $245M → $128M (-$117M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$7.21M |
| 2 |
PVI
Pura Vida Investments
New York
|
+$1.38M |
| 3 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$1.37M |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$1.33M |
| 5 |
BS
Banco Santander
Madrid,
Spain
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$2.68M |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
-$1.78M |
| 3 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.57M |
| 4 |
PMG
ProVise Management Group
Clearwater,
Florida
|
-$1.43M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$1.15M |
APYX Hedge Fund Activity: Q1 2022 in Review
71 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2022, worth a combined $128M — down 48% from $245M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of APYX and 9 opened new positions — a net loss of 4 holders — while 25 trimmed existing stakes and 23 added.
The largest buyer was Cowen and Company, adding an estimated $7.21M. The largest seller was EAM Investors, exiting entirely with an estimated $2.68M sold.
- 71 institutional investors held Apyx Medical (APYX) as of Q1 2022, down from 75 in Q4 2021.
- Funds reported $128M of Apyx Medical stock for Q1 2022, down 48% quarter-over-quarter.
- 9 funds opened new Apyx Medical positions in Q1 2022 and 13 closed out, a net change of -4 holders.
- The largest Apyx Medical buyer in Q1 2022 was Cowen and Company, an estimated $7.21M added.
- The largest Apyx Medical seller in Q1 2022 was EAM Investors, an estimated $2.68M sold.
Based on aggregated 13F filings for Q1 2022.